2-219005543-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_194302.4(CFAP65):c.4942G>A(p.Ala1648Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,459,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_194302.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP65 | NM_194302.4 | c.4942G>A | p.Ala1648Thr | missense_variant | 32/35 | ENST00000341552.10 | NP_919278.2 | |
LOC100129175 | NR_046086.1 | n.86+3243C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP65 | ENST00000341552.10 | c.4942G>A | p.Ala1648Thr | missense_variant | 32/35 | 5 | NM_194302.4 | ENSP00000340776 | A2 | |
ENST00000441450.1 | n.86+3243C>T | intron_variant, non_coding_transcript_variant | 2 | |||||||
CFAP65 | ENST00000453220.5 | c.4942G>A | p.Ala1648Thr | missense_variant | 30/33 | 5 | ENSP00000409117 | A2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1459940Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726250
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.4942G>A (p.A1648T) alteration is located in exon 32 (coding exon 30) of the CFAP65 gene. This alteration results from a G to A substitution at nucleotide position 4942, causing the alanine (A) at amino acid position 1648 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at